Firefly Neuroscience Inc. reported a greater than 20-fold expansion of its commercial footprint and a 33-fold increase in EEG/ERP brain scan volumes. The company said that by the end of 2025 it had 99 commercial users who completed more than 10,800 EEG/ERP brain scans, following its acquisition of Evoke Neuroscience, Inc. Firefly also reported that partner sites and EEG/ERP clinical assessments increased 1,880% and 3,227%, respectively, compared with the end of 2024.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040745PRIMZONEFULLFEED9665671) on March 04, 2026, and is solely responsible for the information contained therein.
Comments